23andMe Taps Dechert To Review CEO Buyout Proposal

By Al Barbarino · April 18, 2024, 5:21 PM EDT

A special committee of genetic testing company 23andMe has engaged Dechert LLP as its legal adviser and Wells Fargo as its financial adviser as it looks to review an anticipated buyout...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Al

November 19, 2024
Kirkland Advises Amcor On $8.4B Berry Global Buy
November 18, 2024
Wachtell-Led CVS Adds Glenview CEO, Others To Board
November 12, 2024
DOJ Suing To Block UnitedHealth Unit's $3.3B Amedisys Deal
November 06, 2024
5 Firms Guide $4.6B Cencora-Retina Consultants Deal
October 30, 2024
Kirkland-Led Francisco Paying $1.1B For AdvancedMD
October 28, 2024
Crown Settles Customer Dispute To Close $924M Revance Buy
October 18, 2024
FTC Faces More Pressure To Block $16.5B Novo-Catalent Deal
October 10, 2024
Sen. Warren, Novo At Odds On Merits Of $16.5B Deal
August 20, 2024
J&J Boosting Cardio Portfolio With Up To $1.7B V-Wave Buy
August 13, 2024
3 Firms Drive $3.8B Carlyle-Baxter Kidney Care Deal